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SINCE substances with antineoplastic activity became available, particularly
those known as biological alkylating agents, systematic histological and cyto-
logical studies of their action have been made (Yoshida, 1952; Jdanov, 1955;
Koller and Veronesi, 1956; Kellner, 1957; Breuvis, 1958; Koller, 1958;
Larionov and Presnov, 1958; Presnov and Spasskaya, 1959).
In this report the histological and histochemical changes that occur in several
experimental tumours following the administration of particular alkylating
agents are described.
MATERIALS AND METHODS
Three transplanted rat tumours were used.
Sarcoma 45.-This is a rat tumour of Russian origin. It is a malignant
spindle-cell tumour, transplantation of which is successful in 100 per cent of
animals, and which kills its host in 25 to 30 days. This tumour regresses
completely with sarcolysine, dopan and ethylene-imino-benzoquinone (E39).
Sarcoma M-1 -This is a malignant, polymorphous-cell tumour of Russiani
origin. On transplantation 100 per cent of grafts are successful, and the tumour
kills its host in 30 days. Sarcoma M-1 is more resistant to chemotherapy than
Sarcoma 45.
Yoshida sarcoma.-This well-known tumour was first introduced into the
Soviet Union in 1957.
All three tumours were transplanted subcutaneously into albino rats of
either sex weighing between 80 and 100 g. The Yoshida sarcoma was also
studied in the ascites form. 633 rats were used.
Chemotherapy was begun when the transplanted tumours were 7 to 10 days
old, measured 0 7 to 1 0 cm. in diameter, and weighed 0 5 to 1P0 g. In the case
of the ascites tumour, treatment was begun 4 days after transplantation.
Three alkylating agents were used: sarcolysine, p-di-(2-chloroethyl)amino-
DL-phenylalanine, (Larionov, Khokhlov, Schkodinskaya, Vasina, Truscheikina,
Novikova-Smirnova, 1955; Truscheikina, 1956; Larionov, 1959) knowin as
merphalan in Great Britain (Bergel and Stock, 1953, 1954; Bergel, Burnop and
Stock, 1955); dopan, 5-di-(2-chloroethyl)amino-4-methyl-uracil (Larionov and
Platonova, 1955; Platonova, 1957; Larionov, 1959); ethylene-imino-benzo-
quinone, E.39, 2, 5-diethylenimino-3,6-dipropoxy-1,4-benzoquinone (Domagk,
Peterson, and Gauss, 1954; Domagk, 1958).CHANGES INDUCED IN RAT SARCOMA BY SARCOLYSINE
Rats bearing Sarcoma 45 received either sarcolysine or dopan; those beariiig
Sarcoma M-1 received only sarcolysine, while rats bearing the Yoshida tumour
received each of the three compounds. The doses and routes of administration of
the drugs are shown in Table I.
TABLE I.-Doses and Routes of Administration of Alkylating
Agents in Transplated Rat Tumours.
Tumour Sarcolysine Dopan E39
Sarcoma A-1 Intraperitoneal
o mg. per kg. 5 to 7
times, 3-day inter-
vals
10 mg. per kg. 5 to 7
times at 3-* or 7-day
intervals
Sarcoma 45 . 15 mg. per kg. once Oral
or in 3-5 divided 0-3 mg. per kg. daily
doses a mg. per kg. for 15 days. or 0 75
at 3-day intervals mg. per kg. 7-9 times
every 3 days
Yoshida solid Intraperitoneal Oral Intraperitoneal
1-5 mg. per kg. daily 0- 3 mg. per kg. daily 0- 6 mg. per kg. daily
for 20 days for 20 days foi 20 days.
Yoshida ascites As above, or orally
* Some rats died.
The histological and histochemical methods used were as follows:
(a) Paraffin-embedded material fixed in 10 per cent neutral formol saline.
Haematoxylin and eosin, Feulgen's method for deoxyribonucleic acid, methyl-
green-pyronin for ribonucleic acid, Van Gieson's stain for collagen, Foot's stain
for reticulin, and toluidine blue for metachromasia.
(b) Frozen sections of material fixed in 10 per cent neutral' formol saline.
Sudan III for neutral fat.
(c) Paraffin-embedded material fixed in cold,80 per cent ethanol. Gomori's
method for alkaline phosphatase. The incubat'ion time was between 2 and 5
hours (Presnov, 1954, 1956).
(d) Paraffin-embedded material fixed by Schabadasch's method (1949).
McManus's modification of Hotchkiss's periodic-acid-Schiff (PAS) method for
polysaccharide.
(e) Methanol-fixed smears of ascitic fluid. May-Grtinwald-Giemsa.
(f) \ital fluorescence microscopy was carried out in collaboration with Dr.
P. V. Breuvis to study the nucleoproteins.
To allow for artefacts in staining, the treated and untreated animals were
killed at the same time, and the tissues from both were handled side by side
throughout each procedure, so that every preparation from a treated tumour
could be compared directly with its counterpart from an untreated tumour which
had been subjected to identical manipulation.
RESULTS
Sarcoma 45 regressed in every animal under treatment with sarcolysine and
dopan, but Sarcoma M-1 regressed completely only after administration of
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sarcolysine at high dosage (five to seven injections at 3-day intervals of 10 mg.
perkg. ofbodyweight). Subcutaneous nodules ofthe Yoshida sarcoma regressed
completely under therapy with sarcolysine or dopan in only 25 per cent of the
rats, and in only 12 per cent when E39 was given. Sarcolysine always caused
complete regression in the ascitic form of Yoshida sarcoma, whether oral or
intraperitoneal routes were employed.
The histological and histochemical changes during the course of regression
were similar in all three tumours and with each of the three drugs.
General histological change8.-During the course ofregression, striking changes
were observed both in the parenchyma and stroma of the tumours. The earliest
changes, decrease in mitotic activity and nuclear fragmentation, were observed
within1 hour of the intraperitoneal injection of sarcolysine in the case of the
Yoshida ascites sarcoma, and in 3 hours in the case of the solid sarcomata, or in
the ascites sarcoma after oral administration. Mitotic activity disappeared if
treatment was continued. Cells in prophase were the first to disappear. Cell
destruction accompanied the decrease in mitotic activity, their nuclei became
angular and the chromatin coarsened. Pyknotic changes were less common.
Abnormal multipolar mitoses appeared. This sequence of changes is illustrated
in Fig. 1-6, 16-24. A very characteristic change was the enlargment of many of
the cells, which has beenfrequently described as a feature ofthe action of alkylat-
ing agents. With further decrease in mitotic activity, bizarre multinucleated
giant cellsappeared, presumably as a result ofamitotic division (Fig. 2, 6, 17, 18).
During treatment the nucleoli of the tumour cells increased in size, showed
increased pyroninophilia and alkaline phosphatase activity.
The stromal and parenchymal changes described did not occursimultaneously
throughout the tumour but were patchy and irregular. In the Yoshida ascites
cells the changes were comparable with those seen in the solid tumours, and
included the appearance ofpathological mitoses, the formation of multinucleated
cells and marked enlargement of the cells and their nuclei and nucleoli (Fig.
22-24).
Changes in thenucleoproteins.-The first change observed was droplet formation
within the nuclei (Fig. 5). The droplets stained deeply with Feulgen's stain
and also showed alkalinephosphatase activity. The nuclei of the greatly enlarged
cells were Feulgen negative almost always, but rarely gave a positive reaction.
Studies on the nucleoproteins in this material, by means of vital fluoresence
microscopy showed that changes occurred 3 to 6 hours after the first treatment
with sarcolysine, and consisted of increased fluoresence in the nuclei of affected
cells (Breuvis, 1958).
Fatty change.-Fat is seen only in small amounts in necrotic areas of the un-
treated tumours, but appeared in the form of small droplets in the cytoplasm of
a majority of the cells 24 to 48 hours after the beginning of treatment. Later all
the cells contained fat, and the small droplets fused into larger ones, becoming
liberated in the stroma as cells disintegrated. Eventually large quantities of
fat accumulated, and this could still be recognised embedded in the scar which
remained after the tumour had regressed completely and had become replaced
by fibrous tissue.
Alkaline phosphatase activity.-In untreated tumours, the enzyme is located
mainly in the nuclei and nucleoli of the cells. Following treatment, it appeared
also in the cytoplasm, while in fragmented nuclei the amount increased greatly.
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Later alkaline phosphatase activity appeared also in the stroma and between the
newly formed collagen fibres (Fig. 7, 8. 9).
Ribonucleic acid.-Pyroninophilia, sometimes after an initial increase,
gradually decreased in the tumour cells, and later disappeared entirely.
Metachromasia.-Cytoplasmic metachromasia with toluidine blue also disap-
peared during treatment.
Glycogen.-Glycogen is not present in untreated tumours, except in lympho-
cytes in the stroma, or in necrotic areas. Glycogen did not appear in the tumour
cells as a result of treatment, though pink droplets, not disappearing after treat-
ment with amylase, appeared (McManus-Hotchkiss reaction). They were
presumably mucopolysaccharide in nature.
Stromal reaction.-The first change was oedema, which separated the tumour
cells slightly from one another. Untreated tumours contain very little collagen,
but argyrophilic fibres are numerous. During treatment, collagen fibres appeared,
became increasingly numerous and eventually formed, a dense scar. During
the same period, the argyrophilic fibres lost their affinity for silver stains, became
thicker and were presumably transformed into collagen fibres (Fig. 10-15).
DISCUSSION
Alkylating agents kill cells. Death may be rapid, and is shown by fragmenta-
tion of the nuclei, or slow, when death is preceded by the appearance of fat in the
cytoplasm, increase in alkaline phosphatase activity, disappearance of ribon-
nucleic acid and of chromotropic substances from the cytoplasm, and by enlarge-
ment of the nuclei and nucleoli. Amitotic division may be a form of dystrophic
change in which the cells, though damaged, can survive. Since large doses of
alkylating agents can cause complete regression of tumours, it is likely that all
the cells are damaged to some extent, and the type and degree of damage may
depend on the functional activity of the cell at the time of exposure, some states
of activity rendering the cell more vulnerable than others. The drugs studied
appear to affect the process of cell division and also to interfere with growth, the
latter effect being relatively small. Sarcolysine appears to suppress the growth
of cells more than dopan or E39.
The alkylating agents appear to act on the tumour cells immediately as shown
by the rapidity with which visible changes in the cells occur, for instance in the
ascites tumours. That nucleoproteins are damaged directly is suggested by the
early occurrence of nuclear fragmentation, increased fluorescence and decrease of
mitotic activity. It is possible that the exact mechanisms vary from one alkylat-
ing agent to another. Powerful agents like sarcolysine might have additional
actions.
It is important to emphasize that the stromal reaction follows the changes
in the tumour cells, and is perhaps directed towards removal of the damaged
tumour cells. It is assumed that increased alkaline phosphatase activity helps
in removing fragmented cell components rich in phosphoesters and nucleic acids.
SUMMARY
1. The histological and histochemical changes accompanying drug-induced
regression were followed in three transplanted rat tumours.
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2. The tumours were the Sarcoma 45, the Sarcoma M-1, and the Yoshida
sarcoma in solid and ascites form.
3. The drugs used were the alkylating agents sarcolysine (merphalan), dopan,
and ethylene-imino-benzoquinone (E39).
4. Eleven histological and histochemical methods were used.
5. Striking parenchymal and stromal changes were observed. Early changes
included decrease in mitotic activity and nuclear fragmentation, while later,
enlargement of surviving cells, and the appearance of multinucleated forms was
seen. Fat appeared in the cytoplasm, and ribonucleoprotein and chromotropic
substances disappeared. In the stroma, the argyrophilic fibres became converted
into collagen. Alkaline phosphatase activity increases first in the cells, and later
in the stroma.
6. The alkylating agents appear to act immediately on the tumour cells. The
stromal reaction is secondary to the death of the tumour cells. The drugs affect
the nucleoproteins directly.
I wish to thank Professor L. F. Larionov for helpful advice.
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